{"id":316,"company":{"country":"IL","currency":"USD","exchange":"TEL AVIV STOCK EXCHANGE","ipo":"2005-09-22","marketCap":34.28293991088867,"name":"Can Fite Biopharma Ltd","phone":"97239241114.0","outstanding":1224.8399658203125,"symbol":"CANF","website":"https://www.canfite.com/","industry":"Biotechnology"},"price":2.018825,"year":2023,"month":11,"day":1,"weekday":"Wednesday","title":"Sentiment Analysis of Can Fite Biopharma Ltd Stock","date":"2023-11-01","url":"/posts/2023/11/01/CANF","content":[{"section":"Analyst Opinions","text":"Analyst opinions on Can Fite Biopharma Ltd stock are mixed. Some analysts are optimistic about the company's prospects and believe that the stock has upside potential. They highlight positive factors such as the company's strong pipeline, potential collaborations, and positive clinical trial results. These analysts recommend buying or holding the stock."},{"section":"Price Targets","text":"Price targets for Can Fite Biopharma Ltd stock vary among analysts. Some analysts have set high price targets, indicating their bullish sentiment and expectations of significant stock price appreciation. Others have more conservative price targets, suggesting a more cautious outlook or lack of confidence."},{"section":"Recommendations","text":"Recommendations for Can Fite Biopharma Ltd stock range from buy to hold to sell. Analysts who recommend buying the stock believe in its long-term potential and expect positive developments in the future. Conversely, analysts who recommend holding or selling the stock express concerns about certain risks or uncertainties associated with the company's operations or market conditions."}],"tags":["CrossOver200","Long","Biotechnology"],"news":[{"category":"company","date":1698674103,"headline":"Can-Fite Biopharma Ltd (CANF) Could Find a Support Soon, Here's Why You Should Buy the Stock Now","id":123505586,"image":"https://media.zenfs.com/en/zacks.com/7ea641b46fe75c0a913349e5e610d6a2","symbol":"CANF","publisher":"Yahoo","summary":"After losing some value lately, a hammer chart pattern has been formed for Can-Fite Biopharma Ltd (CANF), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.","url":"https://finance.yahoo.com/news/fite-biopharma-ltd-canf-could-135503462.html"},{"category":"company","date":1698663600,"headline":"Can Fite: Namodenoson Inhibits Pancreatic Carcinoma Published in Leading Scientific Journal; Robust anti-Cancer Effect \u0026 Molecular Mechanism of Action","id":123494024,"image":"https://media.zenfs.com/en/business-wire.com/3df33047e804a6459d6575e8d6443a60","symbol":"CANF","publisher":"Yahoo","summary":"PETACH TIKVA, Israel, October 30, 2023--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology, inflammatory and liver diseases, today announced that Biomolecules, a peer-reviewed scientific journal focused on function and mechanism of bioactive molecules, published an article titled \"Namodenoson Inhibits the Growth of Pancreatic Carcinoma via Deregulation of the Wnt/β-catenin, NF-κB, and","url":"https://finance.yahoo.com/news/fite-namodenoson-inhibits-pancreatic-carcinoma-110000122.html"},{"category":"company","date":1698415200,"headline":"Best Momentum Stocks to Buy for October 27th","id":123452083,"image":"https://media.zenfs.com/en/zacks.com/24914fc313d586c139cdc39c2921b55a","symbol":"CANF","publisher":"Yahoo","summary":"VRT, PGR and CANF made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 27, 2023.","url":"https://finance.yahoo.com/news/best-momentum-stocks-buy-october-140000507.html"},{"category":"company","date":1698401220,"headline":"New Strong Buy Stocks for October 27th","id":123450500,"image":"https://media.zenfs.com/en/zacks.com/af49e568add9480b4b8deea2c758aa05","symbol":"CANF","publisher":"Yahoo","summary":"MTRX, OPI, CANF, ENLV and RAIL have been added to the Zacks Rank #1 (Strong Buy) List on October 27, 2023.","url":"https://finance.yahoo.com/news/strong-buy-stocks-october-27th-100700179.html"},{"category":"company","date":1698318000,"headline":"Can-Fite to Harness Artificial Intelligence to Develop Novel Anti-Cancer Drugs","id":123421044,"image":"","symbol":"CANF","publisher":"Yahoo","summary":"PETACH TIKVA, Israel, October 26, 2023--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology and inflammatory diseases, today announced that it entered into an agreement with Collaborations Pharmaceuticals, Inc. (CPI) to develop anti-cancer drugs utilizing artificial intelligence (AI) and machine learning (ML) techniques. This project will aim to develop a next-generation A3 adenosine re","url":"https://finance.yahoo.com/news/fite-harness-artificial-intelligence-develop-110000352.html"},{"category":"company","date":1698137280,"headline":"Matson To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Tuesday","id":123364249,"image":"","symbol":"CANF","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3175182980"},{"category":"company","date":1698125520,"headline":"Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Alkermes (ALKS) and Can-Fite BioPharma (CANF)","id":123363792,"image":"","symbol":"CANF","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3174955978"},{"category":"company","date":1698124380,"headline":"Can-Fite BioPharma price target lowered to $18 from $34 at H.C. Wainwright","id":123367459,"image":"","symbol":"CANF","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3174938665"}]}